Pharmaceutical giant Eli Lilly has announced it is instituting a $35 dollar monthly cap on out-of-pocket insulin expenses.
Gold is AU
Pharmaceutical giant Eli Lilly has announced it is instituting a $35 dollar monthly cap on out-of-pocket insulin expenses.